Therapeutic pipeline for analysis of psoriasis is likely to grow on account of increasing prevalence of psoriasis, globally, which is caused due to abnormalities in the immune system caused by external stressors and low market penetration of drugs that can successfully cure the disease. According to the latest data published by the American Academy of Dermatology, approximately 7.5 million people in the U.S. are suffering from psoriasis. The disease is prevalent in people of all age groups, mostly in adults. Both males and females are equally susceptible to this disease.
Psoriasis is a serious condition which includes chronic inflammation and scaling on the skin. Psoriasis develops when skin cells rapidly grow below the surface of the skin and get deposited on the surface before they get mature. Usually this process takes about a month, but in psoriasis it may occur in a few days. Psoriasis leads to the development of thick patches of inflamed skin with a silvery scale covering. These patches are also referred to as plaques and they itch or feel sore. They mostly occur on knees, elbows, other parts of the legs, lower back, scalp, soles of the feet, face and palms. Psoriasis can also affect the toenails, the fingernails, inside the mouth and the soft tissues of the genitals. Pain and itching may interfere with basic functions such as self-care, sleep and walking. Psoriasis is caused when T cells accidently get involved and become active to the extent of triggering other immune responses, thus, resulting in inflammation and rapid turnover of skin cells. Another major source of developing psoriasis is its presence in the family history of an individual. Psoriasis is diagnosed by examining a small skin sample from a patient, under a microscope. There are several forms of psoriasis including guttate psoriasis, plaque psoriasis, erythrodermic psoriasis, inverse psoriasis, pustular psoriasis and psoriatic arthritis. The treatment of psoriasis includes topical treatment, phototherapy and systemic therapy. Topical treatment includes application of ointment or cream forms of corticosteroids, vitamin D3, retinoids, coal tar, or anthralin. Phototherapy includes exposure of UV light in controlled conditions, while systemic treatment includes retinoids, cyclosporine, methotrexate, PDE4 inhibitors and biologic response modifiers medicines.
Request for Table of Content at: https://www.psmarketresearch.com/market-analysis/psoriasis-therapeutic-pipeline-analysis/toc-sample
Some of the leading companies having a pipeline of psoriasis therapeutics include Novartis AG, UCB S.A., Pfizer, GlaxoSmithKline plc, Betta Pharmaceuticals Co., Ltd., AbbVie, Inc., Eli Lilly and Company, Santalis Pharmaceuticals, Inc., Shanghai Celgen Bio-Pharmaceutical Co., Ltd., Janssen Pharmaceuticals, Inc.
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY – 10016
Toll-free: +1-888-778-7886 (USA/Canada)